Introduction and Objectives

Study description
• De-identified patient records from the Cerner Health Facts® EHR database 3 between January 2011
and December 2016 were extracted • Each patient visit (age ≥ 18 years) with a principal inpatient or outpatient ICD-9/10 diagnosis of IBS between 2011 and 2016 were included in the analysis • Visit-based data for medications were examined for this cohort -'Opioid analgesics' were identified as per the VA drug classification system (2016) 4 • Pain scores (Numeric Pain Scale 0-10) during a visit were classified as: 0 to <4 = "Mild"; 4 to <7 = "Moderate"; 7 to 10 = "Severe"; "None" if no scores • The highest pain score per visit was used to assign a pain group (Mild / Moderate / Severe) for every visit
Methods
Conclusions
• This large database analysis examines patient-reported pain scores and opioid usage for IBS visits • These results provide initial insights into potentially relevant practices for prescribing medications in multiple settings of patient care, inpatient and outpatient • Our research highlights high opioid-use in a subset of IBS patient visits • Given the current opioid epidemic, there may be opportunities for improved prescribing Table 4 . Pain score classification
• Opioid analgesics were prescribed in 7.2% (N=3,686) of the total visits and in 68% (N=1,747) of all inpatient stays • Opioid analgesics were prescribed in 43.6% (N=667) of visits with a severe pain score (N=1,530)
